Dabaplex Met Xr 10/1000 30 Tablets

Dabaplex Met Xr 10/1000 30 Tablets

Description:

Dabaplex Met Xr 10/1000 30 Tablets is an oral prescription antidiabetic medicine used to help control blood glucose levels in adults with type 2 diabetes mellitus. It is a fixed-dose combination of a dipeptidyl peptidase-4 (DPP-4) inhibitor (commonly dapagliflozin or a similar agent is used in this therapeutic class) and extended-release metformin, designed for once-daily dosing. The strengths 10/1000 indicate 10 mg of the DPP-4 inhibitor component and 1000 mg of metformin xr per tablet. This combination is typically used when diet, exercise, and metformin alone do not provide adequate glycemic control. Dabaplex Met Xr supports long-term blood sugar management and helps reduce the risk of diabetes-related complications when used as part of a comprehensive diabetes care plan under medical supervision.

Indications:

• Management of type 2 diabetes mellitus in adults, particularly when blood glucose is not adequately controlled with metformin alone, diet, and exercise.
• Helps lower elevated fasting and postprandial (after-meal) blood glucose levels.
• May be used as part of combination therapy with other antidiabetic medications as prescribed by a physician.
• Aims to reduce the risk of long-term complications of uncontrolled diabetes such as neuropathy, nephropathy, retinopathy, and cardiovascular events, as part of an overall treatment plan.

Active Ingredients / Key Components:

• DPP-4 inhibitor (likely dapagliflozin or similar class agent) – 10 mg per tablet (exact active ingredient name and concentration confirmation: information not available on pack; consult the official leaflet or pharmacist).
• Metformin hydrochloride extended-release (metformin xr) – 1000 mg per tablet.
• Other excipients: tablet core and coating agents, binders, fillers, and stabilizers (full excipient list and concentrations: information not available; refer to the official package insert).

Dosage & Administration / How to Use:

• Use only as prescribed by a physician experienced in the management of diabetes.
• Typical adult dose: 1 tablet once daily or as directed by your doctor. The exact dose and frequency depend on your current treatment, blood glucose levels, kidney function, and overall health status.
• Administration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split, as this is an extended-release (xr) formulation.
• Take with the evening meal or as directed by your doctor to help reduce gastrointestinal side effects associated with metformin.
• If a dose is missed, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed tablet.
• Continue following your prescribed diet, exercise program, and regular blood glucose monitoring while using this medication.
• Regular follow-up with your healthcare provider is essential to adjust the dose, monitor kidney function, liver function, and overall glycemic control.

Clinical Benefits:

• Provides dual mechanism of action by combining a DPP-4 inhibitor with metformin xr for more comprehensive blood sugar control.
• Helps lower both fasting and post-meal blood glucose levels, improving overall glycemic profile (hba1c reduction) in type 2 diabetes.
• Extended-release metformin offers smoother, sustained glucose-lowering effect with potentially improved gastrointestinal tolerability compared to immediate-release forms.
• Once-daily dosing supports better treatment adherence and convenience for long-term diabetes management.
• May help reduce the risk of diabetes-related microvascular and macrovascular complications when used as part of a complete therapeutic plan including diet and exercise.

Warnings & Contraindications:

• Contraindicated in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
• Do not use in patients with severe renal impairment, end-stage renal disease, or those on dialysis. Metformin accumulation can lead to lactic acidosis, a rare but serious metabolic complication.
• Use with caution in patients with liver impairment, heart failure, dehydration, severe infection, or conditions associated with hypoxia (e.g., recent myocardial infarction, respiratory failure).
• Discontinue temporarily before iodinated contrast imaging procedures and certain major surgeries, as advised by your doctor, to reduce the risk of lactic acidosis.
• Alcohol intake should be limited or avoided while taking this medicine due to increased risk of lactic acidosis and hypoglycemia.
• May cause hypoglycemia, especially when used with other antidiabetic agents (e.g., insulin, sulfonylureas). Monitor blood glucose regularly.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. The doctor will assess risks and benefits and may adjust therapy.
• Inform your doctor about all medications you are taking, including over-the-counter drugs and herbal supplements, to avoid potential interactions.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects: gastrointestinal discomfort such as nausea, vomiting, diarrhea, abdominal pain, and loss of appetite, especially at the start of therapy (primarily related to metformin).
• Other possible effects: headache, dizziness, mild hypoglycemia (low blood sugar), fatigue, or changes in taste.
• Serious but rare side effect: lactic acidosis (symptoms may include muscle pain, difficulty breathing, unusual tiredness, stomach pain, slow or irregular heartbeat). Seek immediate medical attention if these occur.
• Allergic reactions (rash, itching, swelling of face/lips/tongue, severe dizziness, breathing difficulties) require urgent medical evaluation.
• If you experience persistent or severe side effects, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and moisture. Keep the blister pack or container tightly closed. Do not store above the temperature specified on the package (exact temperature range not available; typically below 25°c unless otherwise stated). Keep out of reach of children.

Specifications:

• Product type: oral antidiabetic medicine (fixed-dose combination).
• Form: film-coated extended-release tablet.
• Strength: 10 mg DPP-4 inhibitor component / 1000 mg metformin xr per tablet (exact DPP-4 agent name and confirmation should be checked on the official pack).
• Count: 30 tablets per pack.
• Intended for: adults with type 2 diabetes mellitus, under medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.